Pathstone Holdings’s Geron GERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,537
Closed -$16.5K 2272
2025
Q4
$16.5K Sell
12,537
-3,431
-21% -$4.3K ﹤0.01% 2211
2025
Q3
$21.9K Sell
15,968
-9,219
-37% -$12.3K ﹤0.01% 2319
2025
Q2
$35.5K Buy
25,187
+7,919
+46% +$11.2K ﹤0.01% 2154
2025
Q1
$27.5K Sell
17,268
-1,923
-10% -$4.68K ﹤0.01% 2196
2024
Q4
$68K Sell
19,191
-1,956
-9% -$7.81K ﹤0.01% 2249
2024
Q3
$96K Buy
21,147
+2,121
+11% +$9.64K ﹤0.01% 2243
2024
Q2
$80.7K Buy
19,026
+115
+0.6% +$448 ﹤0.01% 2238
2024
Q1
$62.4K Buy
18,911
+71
+0.4% +$159 ﹤0.01% 2245
2023
Q4
$39.8K Buy
+18,840
New +$36.6K ﹤0.01% 2173

Other funds holding GERN

Pathstone Holdings's GERN Position: Q1 2026 in Review

Pathstone Holdings sold out of Geron (GERN) in Q1 2026, closing a stake of 12,537 shares — an estimated $16.5K sold.

Pathstone Holdings first reported a position in GERN in Q4 2023 and held it in 9 quarters. The position peaked at $96K in Q3 2024. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.

  • Pathstone Holdings reported no remaining Geron position as of Q1 2026 after selling out during the quarter.
  • Pathstone Holdings sold 12,537 Geron shares in Q1 2026, an estimated $16.5K.
  • Pathstone Holdings first reported a position in Geron in Q4 2023 and held it in 9 quarters.
  • Pathstone Holdings's Geron position peaked at $96K in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.